(Q44232436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Daniel K C Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Kay Haggart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Caroline E Bates

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Brian J Lipworth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

27 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

1232-1238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12456382%20AND%20SRC:MED&resulttype=core&format=json

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Induced Sputum Eicosanoid Concentrations in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Leukotriene antagonists and symptom control in chronic persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Airway inflammation in mild intermittent and in persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Adenosine provocation: a new test for allergic type airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

How best to measure airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Bronchial artery revascularization affects graft recovery after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

The effect of salmeterol on markers of airway inflammation following segmental allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC

The long‐acting β2‐agonist salmeterol xinafoate: effects on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200209-1116OC